USANA Health Sciences, Inc. (NYSE:USNA) Director John Turman Fleming Sells 500 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director John Turman Fleming sold 500 shares of USANA Health Sciences stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $33.30, for a total transaction of $16,650.00. Following the completion of the sale, the director now directly owns 4,026 shares of the company’s stock, valued at approximately $134,065.80. This trade represents a 11.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

USANA Health Sciences Stock Down 1.9 %

Shares of USNA stock opened at $32.49 on Thursday. The stock has a market cap of $619.32 million, a P/E ratio of 11.48, a PEG ratio of 0.93 and a beta of 0.98. USANA Health Sciences, Inc. has a 52 week low of $27.71 and a 52 week high of $50.32. The company’s fifty day simple moving average is $32.86 and its two-hundred day simple moving average is $36.08.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $213.61 million for the quarter, compared to analysts’ expectations of $208.82 million. On average, analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Institutional Trading of USANA Health Sciences

A number of large investors have recently made changes to their positions in USNA. KBC Group NV increased its holdings in shares of USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after buying an additional 519 shares during the last quarter. Royce & Associates LP increased its holdings in shares of USANA Health Sciences by 22.2% in the 3rd quarter. Royce & Associates LP now owns 33,143 shares of the company’s stock worth $1,257,000 after buying an additional 6,031 shares during the last quarter. Quest Partners LLC bought a new position in USANA Health Sciences during the 3rd quarter valued at about $250,000. Pzena Investment Management LLC raised its position in USANA Health Sciences by 7.5% in the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after purchasing an additional 72,977 shares during the period. Finally, Pacer Advisors Inc. raised its position in USANA Health Sciences by 16.5% in the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after purchasing an additional 76,904 shares during the period. 54.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on USNA. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. Finally, DA Davidson lowered their target price on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, February 27th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.